Search Results - Ruiz, Stormy E

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals

    Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals by Bozhanova, Nina G., Flyak, Andrew I., Brown, Benjamin P., Ruiz, Stormy E., Salas, Jordan, Rho, Semi, Bombardi, Robin G., Myers, Luke, Soto, Cinque, Bailey, Justin R., Crowe, James E., Bjorkman, Pamela J., Meiler, Jens

    Published in Nature communications
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein

    An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein by Flyak, Andrew I, Ruiz, Stormy E, Salas, Jordan, Rho, Semi, Bailey, Justin R, Bjorkman, Pamela J

    Published in eLife
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design by Flyak, Andrew I., Ruiz, Stormy, Colbert, Michelle D., Luong, Tiffany, Crowe, James E., Bailey, Justin R., Bjorkman, Pamela J.

    Published in Cell host & microbe
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design

    Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design by Flyak, Andrew I., Ruiz, Stormy, Colbert, Michelle, Luong, Tiffany, Crowe, James E., Bailey, Justin R., Bjorkman, Pamela J.

    Published in Cell host & microbe
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design by Flyak, Andrew I., Ruiz, Stormy, Colbert, Michelle D., Luong, Tiffany, Crowe, Jr., James E., Bailey, Justin R., Bjorkman, Pamela J.

    Published in Cell host & microbe
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design

    HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design by Flyak, Andrew I., Ruiz, Stormy, Colbert, Michelle D., Luong, Tiffany, Crowe, James E., Bailey, Justin R., Bjorkman, Pamela J.

    Published in Cell host & microbe
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract B109: Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design

    Abstract B109: Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design by Flyak, Andrew I., Ruiz, Stormy, Colbert, Michelle, Luong, Tiffany, Crowe, James E., Bailey, Justin R., Bjorkman, Pamela J.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: